List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 9 studies with search of: "Febrile Seizures"
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Antipyretics for Preventing Recurrences of Febrile Seizures
Condition: Recurrence of Febrile Seizure
Intervention: Drug: Diclofenac, Paracetamol, Ibuprofen
2 Not yet recruiting Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Condition: Febrile Seizure
Interventions: Drug: Verum arm receiving Carbogen;   Drug: Placebo
3 Recruiting The Relevance of Performing Lumbar Puncture in Infants Aged 3 to 12 Months With First Episode of Febrile Convulsion
Condition: Febrile Convulsions
Intervention:
4 Unknown † Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age
Conditions: Bronchiolitis;   Gastroenteritis;   Convulsion, Febrile
Intervention:
5 Terminated Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies
Conditions: Parkinson's Disease;   Epilepsy
Intervention:
6 Active, not recruiting
Has Results 		Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
Condition: Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses
Interventions: Biological: GSK Biological's investigational vaccine 209762;   Biological: M-M-R® II (Merck and Co);   Biological: Varivax®;   Biological: Havrix®;   Biological: Prevnar®
7 Completed Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Rubella;   Varicella;   Mumps;   Measles;   Measles-Mumps-Rubella-Varicella Vaccine
Interventions: Biological: PriorixTM;   Biological: VarilrixTM;   Biological: GSK Biologicals' vaccine 208136
8 Completed Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Conditions: Rubella Disease;   Mumps Disease;   Varicella Disease;   Measles Disease
Interventions: Biological: Priorix-Tetra TM (combined measles-mumps-rubella-varicella vaccine);   Biological: GSK Biologicals' 208136, new formulation
9 Completed Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
Conditions: Haemophilus Influenzae Type b Infection;   Meningococcal Infection
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine;   Biological: ActHIB;   Biological: PedvaxHIB;   Biological: Prevnar;   Biological: M-M-R II;   Biological: Pediarix;   Biological: Varivax

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services